MOTION-BASED DRUG DESIGN Trademark

Trademark Overview

On Thursday, May 14, 2020, a trademark application was filed for MOTION-BASED DRUG DESIGN with the United States Patent and Trademark Office. The USPTO has given the MOTION-BASED DRUG DESIGN trademark a serial number of 88915491. The federal status of this trademark filing is REGISTERED as of Tuesday, September 13, 2022. This trademark is owned by Relay Therapeutics, Inc.. The MOTION-BASED DRUG DESIGN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; medical and scientific research services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery
motion-based drug design

General Information

Serial Number88915491
Word MarkMOTION-BASED DRUG DESIGN
Filing DateThursday, May 14, 2020
Status700 - REGISTERED
Status DateTuesday, September 13, 2022
Registration Number6847234
Registration DateTuesday, September 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements

Disclaimer with Predetermined Text"DRUG DESIGN"
Goods and ServicesPharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; medical and scientific research services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 28, 2020
Primary Code042
First Use Anywhere DateSaturday, December 5, 2020
First Use In Commerce DateSaturday, December 5, 2020

Trademark Owner History

Party NameRelay Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, September 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 13, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, August 11, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 10, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 25, 2022USE AMENDMENT FILED
Wednesday, June 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, May 25, 2022SOU EXTENSION 3 FILED
Monday, June 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 25, 2022TEAS STATEMENT OF USE RECEIVED
Friday, May 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 25, 2022SOU EXTENSION 2 GRANTED
Wednesday, May 25, 2022SOU EXTENSION 2 FILED
Wednesday, May 25, 2022TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 1 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 1 FILED
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020NON-FINAL ACTION WRITTEN
Wednesday, August 12, 2020ASSIGNED TO EXAMINER
Thursday, May 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 18, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

design drug based motion research pharmaceutical services development discovery medicines field preparations scientific